Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Using cre/loxP gene targeting, transgenic mice with muscle-specific inactivation of the GLUT4 gene (muscle GLUT4 KO) were generated and shown to develop a diabetes phenotype. To determine the mechanism, we examined insulin-stimulated glucose uptake and metabolism during hyperinsulinemic-euglycemic clamp in control and muscle GLUT4 KO mice before and after development of diabetes. Insulin-stimulated whole body glucose uptake was decreased by 55% in muscle GLUT4 KO mice, an effect that could be attributed to a 92% decrease in insulin-stimulated muscle glucose uptake. Surprisingly, insulin's ability to stimulate adipose tissue glucose uptake and suppress hepatic glucose production was significantly impaired in muscle GLUT4 KO mice. To address whether these latter changes were caused by glucose toxicity, we treated muscle GLUT4 KO mice with phloridzin to prevent hyperglycemia and found that insulin-stimulated whole body and skeletal muscle glucose uptake were decreased substantially, whereas insulin-stimulated glucose uptake in adipose tissue and suppression of hepatic glucose production were normal after phloridzin treatment. In conclusion, these findings demonstrate that a primary defect in muscle glucose transport can lead to secondary defects in insulin action in adipose tissue and liver due to glucose toxicity. These secondary defects contribute to insulin resistance and to the development of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In genetic mouse models of muscle-specific IR, by deleting the IRTK [142] or GLUT4 [143] genes, hepatic steatosis and adiposity were increased [142].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
Glucose Transporters and Insulin Action — Implications for Insulin Resistance and Diabetes Mellitus
Shepherd, P. R., & Kahn, B. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410406 · Cited by 1,295
Self-citationShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248 · cited 2×
“Skeletal muscle is responsible for the majority of whole body insulinmediated glucose metabolism (4, 5), and insulin promotes glucose transport in this tissue by stimulating the translocation of the major insulin-responsive glucose transporter, GLUT4, from intracellular storage vesicles to the plasma membrane (6–8).”
BackgroundSelf-citationBrüning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L. J., & Kahn, C. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80155-0 · Cited by 1,182
Self-citationWarram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Self-citationZisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743 · cited 8×
“Although Zisman and colleagues observed mild hyperglycemia at 8 weeks of age when mice were continuously housed in their original site (12), in this related cohort, which underwent shipping and surgery and a related mild weight loss, the plasma glucose concentration was normal at approximately 10 weeks of age.”
BackgroundMethodResultInfluentialSelf-citationCline, G. W., Petersen, K. F., Krssak, M., Shen, J., Hundal, R. S., Trajanoski, Z., Inzucchi, S., Dresner, A., Rothman, D. L., & Shulman, G. I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410404 · Cited by 675
Self-citationShepherd, P. R., Gnudi, L., Tozzo, E., Yang, H., Leach, F., & Kahn, B. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41516-5 · Cited by 522
Self-citation
Cited by
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
“analysis was performed as described previously (43), with minor modifi-”
MethodInsulin Receptor Signaling in Normal and Insulin-Resistant States
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,473
“Hyperglycemia induced by decreased glucose transport in skeletal muscle impairs adipose and hepatic insulin action (Zisman et al. 2000; Kim et al. 2001b) and induces insulin resistance through several pathways, which are all believed to be linked to oxidative stress (Evans et al.”
BackgroundSelf-citationThe pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484
“This has been observed in genetic mouse models of selective muscle insulin resistance due to muscle-specific deletions of the IRTK (27) and GLUT4 (60), which are prone to hepatic steatosis (61) and increased adiposity (27).”
BackgroundSelf-citationHuang, S., & Czech, M. P. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.006 · Cited by 1,385
Lipid-induced insulin resistance: unravelling the mechanism
Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60408-4 · Cited by 1,189
Self-citationThe role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136
Self-citationInsulin Resistance: From Mechanisms to Therapeutic Strategies
Lee, S.-H., Park, S.-Y., & Choi, C. S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0280 · Cited by 1,092
“Muscle-specific insulin resistance by the muscle-specific deletion of IRTK or GLUT4 increased the susceptibility to hepatic steatosis, and increase adiposity in animal models [29,30].”
BackgroundAyala, J. E., Samuel, V. T., Morton, G. J., Obici, S., Croniger, C. M., Shulman, G. I., Wasserman, D. H., & McGuinness, O. P. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.006239 · Cited by 716
“at the end of the equilibration period) or by completely eliminating the first priming dose and giving the priming dose only at the end of the equilibration period (Fernandez et al., 2001; Kim et al., 2001; Haluzik et al., 2002; Kim, H. et al., 2003; Kim, J. K. et al., 2003; Spurlin et al., 2003; Haluzik et al., 2004b…”
BackgroundSelf-citationThe aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 690
Functional Properties and Genomics of Glucose Transporters
Zhao, F.-Q., & Keating, A. (2007) · Current Genomics · doi:10.2174/138920207780368187 · Cited by 549
Stiles, B., Wang, Y., Stahl, A., Bassilian, S., Lee, W. P., Kim, Y.-J., Sherwin, R., Devaskar, S., Lesche, R., Magnuson, M. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308617100 · Cited by 436
Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
Han, S., Hagan, D. L., Taylor, J. R., Xin, L., Meng, W., Biller, S. A., Wetterau, J. R., Washburn, W. N., & Whaley, J. M. (2008) · Diabetes · doi:10.2337/db07-1472 · Cited by 421
“Phlorizin, a relatively nonselective but potent inhibitor of the sodium-glucose cotransporters (SGLTs) which mediate renal reabsorption and intestinal absorption of glucose (11), has been demonstrated to be glucosuric and antihyperglycemic in diabetic animal models (3-10).”
BackgroundNorris, A. W., Chen, L., Fisher, S. J., Szanto, I., Ristow, M., Jozsi, A. C., Hirshman, M. F., Rosen, E. D., Goodyear, L. J., Gonzalez, F. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17305 · Cited by 417
“The glucose homeostasis defect in M-G4KO mice is more severe, and they develop secondary insulin resistance in liver and adipose tissue mediated by glucose toxicity (45).”
BackgroundMethodSelf-citationConsiderations in the Design of Hyperinsulinemic-Euglycemic Clamps in the Conscious Mouse
Ayala, J. E., Bracy, D. P., McGuinness, O. P., & Wasserman, D. H. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0686 · Cited by 403
Tzatsos, A., & Kandror, K. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.63-76.2006 · Cited by 399
“The resulting hyperglycemia antagonizes metabolic and prosurvival effects of PI3kinase/Akt signaling in vivo (28) and in vitro (18, 19), a phenomenon known as glucotoxicity.”
BackgroundNishino, N., Tamori, Y., Tateya, S., Kawaguchi, T., Shibakusa, T., Mizunoya, W., Inoue, K., Kitazawa, R., Kitazawa, S., Matsuki, Y., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34090 · Cited by 392
“The rates of glucose disposal and hepatic glucose production were calculated as described (47).”
MethodHong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390
“In genetic mouse models of muscle-specific IR, by deleting the IRTK [142] or GLUT4 [143] genes, hepatic steatosis and adiposity were increased [142].”
BackgroundInfluentialGlucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony
Herman, M. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29027 · Cited by 355
Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue
Yu, Y.-H., & Ginsberg, H. N. (2005) · Circulation Research · doi:10.1161/01.res.0000165803.47776.38 · Cited by 326
Hepatic Glucose Sensing via the CREB Coactivator CRTC2
Dentin, R., Hedrick, S., Xie, J., Yates, J., & Montminy, M. (2008) · Science · doi:10.1126/science.1151363 · Cited by 319
Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
Jornayvaz, F. R., & Shulman, G. I. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.005 · Cited by 317
Self-citationSirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation
Jing, E., O’Neill, B. T., Rardin, M. J., Kleinridders, A., Ilkeyeva, O. R., Ussar, S., Bain, J. R., Lee, K. Y., Verdin, E. M., Newgard, C. B., et al. (2013) · Diabetes · doi:10.2337/db12-1650 · Cited by 283
“In the fed state, the main fuel source in muscle is insulin-induced glucose metabolism (1,2); during fasting, muscle switches its fuel utilization from glucose to lipid oxidation (3).”
BackgroundSelf-citationMouse models of insulin resistance
Hribal, M. L., Oriente, F., & Accili, D. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2001 · Cited by 252
Carvalho, E., Kotani, K., Peroni, O. D., & Kahn, B. B. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00116.2005 · Cited by 238
“Nevertheless, the increase in glucose transport in WAT may contribute to the restoration of glucose homeostasis.”
BackgroundMethodInfluentialSelf-citationMouse Models of Insulin Resistance
NANDI, A., KITAMURA, Y., KAHN, C. R., & ACCILI, D. (2004) · Physiological Reviews · doi:10.1152/physrev.00032.2003 · Cited by 231
Self-citationMinokoshi, Y., Kahn, C. R., & Kahn, B. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300019200 · Cited by 220
Self-citationGenetic Modulation of PPARγ Phosphorylation Regulates Insulin Sensitivity
Rangwala, S. M., Rhoades, B., Shapiro, J. S., Rich, A. S., Kim, J. K., Shulman, G. I., Kaestner, K. H., & Lazar, M. A. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00274-0 · Cited by 204
Self-citationAngiotensin II and the development of insulin resistance: Implications for diabetes
Olivares-Reyes, J. A., Arellano-Plancarte, A., & Castillo-Hernandez, J. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.011 · Cited by 202
“lucose uptake accounts for only a small part of that for the whole ody, the mechanism of insulin action in this tissue is of utmost mportance (Juan et al., 2005; Kim et al., 2001).”
BackgroundMuscle and adipose tissue insulin resistance: malady without mechanism?
Fazakerley, D. J., Krycer, J. R., Kearney, A. L., Hocking, S. L., & James, D. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r087510 · Cited by 185
“adipose or muscle tissue or both, leads to whole body insulin resistance and hyperinsulinemia (95, 98-102).”
BackgroundKobayashi, M., Ohsugi, M., Sasako, T., Awazawa, M., Umehara, T., Iwane, A., Kobayashi, N., Okazaki, Y., Kubota, N., Suzuki, R., et al. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00116-18 · Cited by 169
“Blood samples from tail-tip bleeds were collected 80, 90, 100, 110, and 120 min after the onset of the clamp, and measurements of [3-3H]glucose-specific activity and calculation of the rates of glucose disappearance (Rd) and hepatic glucose production (HGP) rates were performed as described previously (50).”
MethodLee, J., Kim, B., Kim, W., Ahn, C., Choi, H. Y., Kim, J. G., Kim, J., Shin, H., Kang, J. G., & Moon, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82053-2 · Cited by 156
Self-citationFarese, R. V., Sajan, M. P., Yang, H., Li, P., Mastorides, S., Gower, W. R., Nimal, S., Choi, C. S., Kim, S., Shulman, G. I., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31408 · Cited by 169
Self-citationYechoor, V. K., Patti, M.-E., Saccone, R., & Kahn, C. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142301999 · Cited by 156
Self-citationHuh, M. S., Parker, M. H., Scimè, A., Parks, R., & Rudnicki, M. A. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403004 · Cited by 156
“The MCK-Cre transgene has been used extensively to efficiently and completely excise floxed alleles in terminally differentiated cardiac and skeletal muscle (Wang et al., 1999; Zisman et al., 2000; Kim et al., 2001; Andrechek et al., 2002; Norris et al., 2003).”
MethodHyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Ayala, J. E., Bracy, D. P., Malabanan, C., James, F. D., Ansari, T., Fueger, P. T., McGuinness, O. P., & Wasserman, D. H. (2011) · Journal of Visualized Experiments · doi:10.3791/3188-v · Cited by 56
“these data as time courses is significantly more informative than the conventional practice in the mouse insulin clamp literature of presenting a 2hour experiment as a single datum point representing average values from an undefined "clamp" period (4-13).”
BackgroundMiyake, K., Ogawa, W., Matsumoto, M., Nakamura, T., Sakaue, H., & Kasuga, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15880 · Cited by 147
“Although several mouse models have been established that lack a specific protein in a specific tissue, these models have still exhibited abnormalities in multiple organs, probably due to secondary effects of chronic metabolic alterations (15, 16).”
Jurczak, M. J., Lee, A.-H., Jornayvaz, F. R., Lee, H.-Y., Birkenfeld, A. L., Guigni, B. A., Kahn, M., Samuel, V. T., Glimcher, L. H., & Shulman, G. I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316760 · Cited by 143
Self-citationLamia, K. A., Peroni, O. D., Kim, Y.-B., Rameh, L. E., Kahn, B. B., & Cantley, L. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.5080-5087.2004 · Cited by 120
“However, the physiology of glucose homeostasis is controlled by complex communication between multiple tissues, including the brain (1, 4, 5, 18, 19, 24).”
BackgroundSelf-citationKotani, K., Peroni, O. D., Minokoshi, Y., Boss, O., & Kahn, B. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421341 · Cited by 139
“and (3)H2O concentrations as previously described (33).”
Self-citationGlucose Metabolism in Mice Lacking Muscle Glycogen Synthase
Pederson, B. A., Schroeder, J. M., Parker, G. E., Smith, M. W., DePaoli-Roach, A. A., & Roach, P. J. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3466 · Cited by 120
“Elimination of muscle GLUT4 leads to a more severe phenotype, with impaired muscle glucose uptake and the development of diabetes in a subset of the mice (24,25).”
BackgroundEsteves, J. V. D. C., Enguita, F. J., & Machado, U. F. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7267910 · Cited by 121
“Besides, transgenic animals with muscle-specific inactivation of GLUT4 show a diabetic phenotype [50, 51], and the muscle-specific GLUT4 overexpression in diabetic animals improves glycemic control [52, 53], pointing out the fundamental role of GLUT4 in glycemic homeostasis [7].”
BackgroundEpigallocatechin gallate promotes GLUT4 translocation in skeletal muscle
Ueda, M., Nishiumi, S., Nagayasu, H., Fukuda, I., Yoshida, K., & Ashida, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.128 · Cited by 124
Preitner, F., Mody, N., Graham, T. E., Peroni, O. D., & Kahn, B. B. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2009 · Cited by 106
Self-citationGiaccari, A., Sorice, G. P., & Muscogiuri, G. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.03.018 · Cited by 121
“After phloridzin treatment, the impairment in muscle glucose utilisation was still decreased, but the uptake in the other tissues was restored [11], thus confirming the role of glucose toxicity in impairing glucose uptake.”
BackgroundChavanelle, V., Boisseau, N., Otero, Y. F., Combaret, L., Dardevet, D. P., Montaurier, C., Delcros, G., Peltier, S. L., & Sirvent, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-00276-8 · Cited by 121
Metabolic Adaptations in the Absence of Perilipin
Saha, P. K., Kojima, H., Martinez-Botas, J., Sunehag, A. L., & Chan, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405499200 · Cited by 104
Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, E., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 97
Cellular and Molecular Mechanisms of Insulin Resistance
Chandrasekaran, P., & Weiskirchen, R. (2024) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-024-00056-3 · Cited by 142
“Multiple studies have found that impaired translocation of GLUT4 protein is responsible for IR in skeletal muscle [31].”
Tateya, S., Tamori, Y., Kawaguchi, T., Kanda, H., & Kasuga, M. (2010) · Endocrinology · doi:10.1210/en.2009-0926 · Cited by 98
V. Chartoumpekis, D., & W. Kensler, T. (2013) · Current Diabetes Reviews · doi:10.2174/157339913805076490 · Cited by 104
AS160 deficiency causes whole-body insulin resistance via composite effects in multiple tissues
Wang, H. Y., Ducommun, S., Quan, C., Xie, B., Li, M., Wasserman, D. H., Sakamoto, K., Mackintosh, C., & Chen, S. (2013) · Biochemical Journal · doi:10.1042/bj20120702 · Cited by 91
Iozzo, P., Hallsten, K., Oikonen, V., Virtanen, K. A., Kemppainen, J., Solin, O., Ferrannini, E., Knuuti, J., & Nuutila, P. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021446 · Cited by 90
Shao, J., Qiao, L., Janssen, R. C., Pagliassotti, M., & Friedman, J. E. (2005) · Diabetes · doi:10.2337/diabetes.54.4.976 · Cited by 90
“Therefore, the current study, using an in vivo system, has identified an important molecular mechanism that mediates hyperglycemia-induced dysregulation of HGP at the level of the PEPCK promoter.”
BackgroundInfluentialHexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes
Teo, C. F., Wollaston‐Hayden, E. E., & Wells, L. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.022 · Cited by 90
Glucose Transporter-4 Facilitates Insulin-Stimulated Glucose Uptake in Osteoblasts
Li, Z., Frey, J. L., Wong, G. W., Faugere, M.-C., Wolfgang, M. J., Kim, J. K., Riddle, R. C., & Clemens, T. L. (2016) · Endocrinology · doi:10.1210/en.2016-1583 · Cited by 86
Self-citationKnockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance
Mauvais‐Jarvis, F., Kulkarni, R. N., & Kahn, C. R. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01563.x · Cited by 83
“Indeed, transgenic mice with muscle- or liver-specific overexpression of lipoprotein lipase exhibit increased triglyceride tissue content that correlates with insulin resistance (Kim et al., 2001).”
BackgroundSelf-citationMacauley, M. S., Shan, X., Yuzwa, S. A., Gloster, T. M., & Vocadlo, D. J. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.005 · Cited by 78
“Hyperglycemia has long been known to cause insulin desensitization (Kim et al., 2001; Nawano et al., 2000; Nelson et al., 2002; van Putten and Krans, 1985).”
Papa, P. D. C., Vargas, A. M., da Silva, J. L. T., Nunes, M. T., & Machado, U. F. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01948-3 · Cited by 83
Hong, E., Jung, D. Y., Ko, H. J., Zhang, Z., Ma, Z., Jun, J. Y., Kim, J. H., Sumner, A. D., Vary, T. C., Gardner, T. W., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00256.2007 · Cited by 76
Self-citationDouillard‐Guilloux, G., Raben, N., Takikita, S., Ferry, A., Vignaud, A., Guillet-Deniau, I., Favier, M., Thurberg, B. L., Roach, P. J., Caillaud, C., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp535 · Cited by 71
“Elimination of muscle GLUT4 leads to a more severe phenotype, with impaired muscle glucose uptake and the development of diabetes in a subset of mice (31,32).”
BackgroundEsteves, J. V. D. C., Yonamine, C. Y., Júnior, D. A. C. P., Gerlinger‐Romero, F., Enguita, F. J., & Machado, U. F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00536 · Cited by 65
“Indeed, muscle-specific deletion of GLUT4 promotes insulin resistance, glucose intolerance and hyperglycemia (16, 17); whereas musclespecific GLUT4 overexpression in diabetic animals improves insulin sensitivity and glycemic control (18, 19).”
BackgroundUeda, M., Hayashibara, K., & Ashida, H. (2013) · BioFactors · doi:10.1002/biof.1085 · Cited by 73
Serra, C., Federici, M., Buongiorno, A., Senni, M. I., Morelli, S., Segratella, E., Pascuccio, M., Tiveron, C., Mattei, E., Tatangelo, L., et al. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10278 · Cited by 64
“In fact, muscle GLUT4 inactivation causes insulin resistance and glucose intolerance (Zisman et al., 2000), and the resulting glucose toxicity may contribute to the observed insulin resistance and the development of diabetes (Kim et al., 2001).”
BackgroundZhao, H., Yakar, S., Gavrilova, O., Sun, H., Zhang, Y., Kim, H., Setser, J., Jou, W., & LeRoith, D. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2901 · Cited by 73
“(16) demonstrated that glucotoxicity that occurs in response to muscle-specific inactivation of the glucose transporter GLUT4 (muscle GLUT4 knockout) can lead to secondary defects in insulin action in adipose tissue and liver.”
BackgroundResultCho, Y.-R., Kim, H.-J., Park, S.-Y., Ko, H. J., Hong, E.-G., Higashimori, T., Zhang, Z., Jung, D. Y., Ola, M. S., LaNoue, K. F., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00376.2006 · Cited by 64
Self-citationWakagi, M., Hayashibara, K., Nagano, T., Ikeda, M., Yuan, S., Ueda, S., Shirai, Y., Yoshida, K., & Ashida, H. (2018) · Food & Function · doi:10.1039/c8fo00807h · Cited by 62
Farnesoid X Receptor Induces GLUT4 Expression Through FXR Response Element in the GLUT4 Promoter
Shen, H., Zhang, Y., Ding, H., Wang, X., Chen, L., Jiang, H., & Shen, X. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000149779 · Cited by 69
Changes in Cells Associated with Insulin Resistance
Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042397 · Cited by 88
“Insulin resistance in skeletal muscle, due to the deletion of insulin receptor tyrosine kinase (IRTK) or GLUT4, increases adiposity in animal models [121,122].”
BackgroundRichter, E. A., Bilan, P. J., & Klip, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00033.2024 · Cited by 64
Burcelin, R., Crivelli, V., Perrin, C., Costa, A. D., Mu, J., Kahn, B. B., Birnbaum, M. J., Kahn, C. R., Vollenweider, P., & Thorens, B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16888 · Cited by 69
“Indeed, activation by portal glucose infusion is blocked by coinfusion of the GLP-1 antagonist exendin-(9-39) and is undetectable in GLP-1 receptor knockout mice (11).”
BackgroundSelf-citationKim, Y.-B., Peroni, O. D., Aschenbach, W. G., Minokoshi, Y., Kotani, K., Zisman, A., Kahn, C. R., Goodyear, L. J., & Kahn, B. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9713-9723.2005 · Cited by 58
Self-citationHaines, M. S., Dichtel, L. E., Santoso, K., Torriani, M., Miller, K. K., & Bredella, M. A. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0590-y · Cited by 64
“contribute to insulin resistance (IR) and T2DM [5, 6].”
BackgroundGlucose transport in the equine hoof
Asplin, K. E., Curlewis, J. D., McGowan, C. M., Pollitt, C. C., & Sillence, M. N. (2010) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.2010.00127.x · Cited by 70
“Insulin resistance occurs when either the translocation or functional capabilities of the GLUT4 protein are impaired (Garvey et al. 1998; Kim et al. 2001).”
BackgroundBurcelin, R., Crivelli, V., Perrin, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316888 · Cited by 57
Self-citationKnockout Mice Challenge our Concepts of Glucose Homeostasis and the Pathogenesis of Diabetes
Kahn, C. R. (2003) · Journal of Diabetes Research · doi:10.1155/edr.2003.169 · Cited by 56
“Intraperitoneal insulin injection and contraction produced no fall in glucose levels in male MG4KO and only a 34% fall in female MG4KO (p .03).”
BackgroundInfluentialSelf-citationLi, Z., Sun, F., Zhang, Y., Chen, H., He, N., Chen, H., Song, P., Wang, Y., Yan, S., & Zheng, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143405 · Cited by 56
“Toxic effects of hyperglycemia [30], toxicity of TAC [11], and excessive secretion by βcells due to insulin resistance, all contributed to impairment of β-cell function, which eventually lead to hypoinsulinemia.”
BackgroundZhang, S., Yang, Q., Ren, M., Qiao, S., He, P., Li, D., & Zeng, X. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516002439 · Cited by 60
“Obesity contributes to type 2 diabetes with the down-regulated expressions of GLUT1 and GLUT4 in skeletal muscle (2,3) .”
BackgroundMaeda, A., Shirao, T., Shirasaya, D., Yoshioka, Y., Yamashita, Y., Akagawa, M., & Ashida, H. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800086 · Cited by 238
Angiotensin II Enhances Insulin Sensitivity in Vitro and in Vivo
Juan, C., Chien, Y., Wu, L.-Y., Yang, W.-M., Chang, C.-L., Lai, Y., Ho, P., Kwok, C., & Ho, L.-T. (2005) · Endocrinology · doi:10.1210/en.2004-1136 · Cited by 56
“Mice carrying an adipose tissue-specific deletion of the GLUT4 gene rapidly develop marked muscular and hepatic insulin resistance (32), whereas mice carrying a muscle-specific deletion of GLUT4 develop hepatic and adipose insulin resistance secondary to the resulting hyperglycemia (33).”
BackgroundNorris, A. W., Chen, L., Fisher, S. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317305 · Cited by 53
Self-citationMouse models created to study the pathophysiology of Type 2 diabetes
LeRoith, D., & Gavrilova, O. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.01.019 · Cited by 60
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Armandi, A., Rosso, C., Caviglia, G. P., Ribaldone, D. G., & Bugianesi, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716533 · Cited by 48
“org 5 In turn, SM IR can worsen liver steatosis through direct glucotoxicity, as shown by studies conducted on knockout mice for SM-restricted GLUT4 (58), where undisposed glucose is addressed to hepatic de novo lipogenesis, increasing intracellular lipid load.”
BackgroundPlum, L., Wunderlich, F. T., Baudler, S., Krone, W., & Brüning, J. C. (2005) · Physiology · doi:10.1152/physiol.00049.2004 · Cited by 64
Alonso, L. C., Watanabe, Y., Stefanovski, D., Lee, E. J., Singamsetty, S., Romano, L. C., Zou, B., Garcia‐Ocaña, A., Bergman, R. N., & O'Donnell, C. P. (2012) · Obesity · doi:10.1038/oby.2012.36 · Cited by 46
McMillin, S. L., Schmidt, D. L., Kahn, B. B., & Witczak, C. A. (2017) · Diabetes · doi:10.2337/db16-1075 · Cited by 45
“Overload-Induced Muscle Hypertrophy Is Not Impaired in mGLUT4 KO Mice Previous work demonstrated that muscle-specific loss of GLUT4 led to slight (10–15%) or nonsignificant alterations in mouse body weight (11,12,24), and this small difference in phenotype was attributed to the heterogeneity of the background strain (…”
Self-citationFasting Hyperglycemia Impairs Glucose- But Not Insulin-Mediated Suppression of Glucagon Secretion
Abdul-Ghani, M., & DeFronzo, R. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1515 · Cited by 46
Tanrıkulu-Kılıç, F., Bekpınar, S., Ünlüçerçi, Y., & Orhan, Y. (2006) · Physiological Research · doi:10.33549/physiolres.930745 · Cited by 45
Fujimoto, Y., Torres, T. P., Donahue, E. P., & Shiota, M. (2006) · Diabetes · doi:10.2337/db05-1511 · Cited by 50
Kawaguchi, T., Tamori, Y., Kanda, H., Yoshikawa, M., Tateya, S., Nishino, N., & Kasuga, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.045 · Cited by 47
Kim, A., Koo, J. H., Jin, X., Kim, W., Park, S., Park, S., Rhee, E. P., Choi, C. S., & Kim, S. G. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12777 · Cited by 44
“and metabolic disorders by loading ingested glucose and FAs to different organs,(25) and thus, glucose intolerance in skeletal muscle promotes obesity.(26,27) Consistently, the skeletal muscle-specific ablation of USP21 in our study had a beneficial effect on systemic insulin sensitivity.”
BackgroundIncreasing effect of Tangzhiqing formula on IRS-1-dependent PI3K/AKT signaling in muscle
Gao, J., Li, J., An, Y., Liu, X., Qian, Q., Wu, Y., Zhang, Y., & Wang, T. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-198 · Cited by 36
“Several research groups reported that GluT4 content in skeletal muscle is highly related to insulin resistance, primary defect in insulin-stimulated muscle glucose uptake can cause insulin resistance in other insulin-responsive organs, such as liver and adipocytes, and subsequently result in the development of diabete…”
BackgroundLima, A. F., Ropelle, E. R., Pauli, J. R., Cintra, D. E., Frederico, M. J. S., Pinho, R. A., Velloso, L. A., & de Souza, C. T. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21833 · Cited by 41
“K pathway is involved in hepatic glucose production (Kim et al., 2001), we may suggest that physical activity partially reverses insulin resistance of diabetic mice by acting on this pathway, following acute exercise.”
BackgroundDas, U. N. (2013) · Clinical Lipidology · doi:10.2217/clp.13.32 · Cited by 37
Yonamine, C. Y., Teixeira, S. D. S., Campello, R. S., Gerlinger‐Romero, F., Rodrigues, C., Guimarães‐Ferreira, L., Machado, U. F., & Nunes, M. T. (2014) · Acta Physiologica · doi:10.1111/apha.12336 · Cited by 36
“Likewise, muscle GLUT4 KO mice develop insulin resistance (Kim et al. 2001).”
BackgroundGα13 ablation reprograms myofibers to oxidative phenotype and enhances whole-body metabolism
Koo, J. H., Kim, T. H., Park, S., Joo, M. S., Han, C. Y., Choi, C. S., & Kim, S. G. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92067 · Cited by 38
“Genetic models of selective insulin resistance in the muscle were also prone to developing hepatic steatosis and obesity (47, 48).”
BackgroundPrevention of colon carcinogenesis by apple juicein vivo: Impact of juice constituents and obesity
Koch, T. C. L., Briviba, K., Watzl, B., Fähndrich, C., Bub, A., Rechkemmer, G., & Barth, S. W. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800457 · Cited by 39
“Additionally, polyphenols such as phlorizin, which reduce intestinal absorption of glucose, may avoid the development of insulin resistance and improve insulin sensitivity by preventing prolonged hyperglycemia [22, 23].”
BackgroundAbdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance
Flowers, J. B., Oler, A. T., Nadler, S. T., Choi, Y., Schueler, K. L., Yandell, B. S., Kendziorski, C. M., & Attie, A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00370.2006 · Cited by 35
“Clamp hepatic glucose output was determined by subtracting the average steady-state glucose infusion rate in the last 40 min of the clamp from the whole body glucose uptake (45).”
MethodInfluentialNormal muscle glucose uptake in mice deficient in muscle GLUT4
Fam, B. C., Rose, L. J., Sgambellone, R., Ruan, Z., Proietto, J., & Andrikopoulos, S. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0032 · Cited by 34
Shen, L., Gan, M., Zhang, S., Ma, J., Tang, G., Jiang, Y., Li, M., Wang, J., Li, X., Che, L., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00291 · Cited by 36
Xiao, D., Zhou, T., Fu, Y., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.036 · Cited by 30
Metadata
- Authors
- Kim, J. K., Zisman, A., Fillmore, J. J., Peroni, O. D., Kotani, K., Perret, P., Zong, H., Dong, J., Kahn, C. R., Kahn, B. B., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- Joslin Diabetes Center (US)
- Yale University (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Shulman, Gerald I.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-07-01
- Volume
- 108
- Issue
- 1
- Pages
- 153-160
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC353719
- OpenAlex
- W2153764436
- Cited by
- 202
- References
- 41
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 5 · 2022: 3 · 2021: 12 · 2020: 7 · 2019: 4 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 4 · 2014: 6 · 2013: 7 · 2012: 8
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- U.S. Public Health Service (P30 DK45735, R01 DK-40936)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK45735, R01-DK40936, R01 DK43051, U24DK59635, R01DK080756, R01DK040936, U24DK059635, R01 DK-33201, R01DK033201, R01DK043051, P30DK045735)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- glucotoxicity, GLUT4, skeletal muscle glucose transport, type 2 diabetes, insulin resistance, insulin-stimulated glucose uptake, adipose tissue glucose uptake, hepatic glucose production, phloridzin, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Adipose Tissue, Animals, Depression, Chemical, Diabetes Mellitus, Type 2, Disease Models, Animal, Glucose, Hyperglycemia, Insulin, Insulin Infusion Systems, Insulin Resistance, Kidney Tubules, Liver, Male, Monosaccharide Transport Proteins, Muscle Proteins, Phlorhizin, Prediabetic State, Age of Onset, Mice, Knockout, Muscle, Skeletal, Protein Transport, Glucose Transporter Type 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.